Residential College | false |
Status | 已發表Published |
Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer | |
Zhou, Xintong1; Wang, Xiaomin2; Sun, Qi3; Zhang, Wenfeng4; Liu, Cun2; Ma, Wenzhe5; Sun, Changgang6,7,8 | |
2022-07-01 | |
Source Publication | Biomedicine and Pharmacotherapy |
ISSN | 0753-3322 |
Volume | 151 |
Abstract | With the development in tumor immunology, people are gradually understanding the complexity and diversity of the tumor microenvironment immune status and its important effect on tumors. Tumor-associated macrophages (TAMs), an important part of the tumor immune microenvironment, have a double effect on tumor growth and metastasis. Many studies have focused on lung cancer, especially non-small cell lung cancer and other “hot tumors” with typical inflammatory characteristics. The polarization and infiltration of TAMs is an important mechanism in the occurrence and development of malignant tumors, such as lung cancer, and in the tumor immune microenvironment. Therapeutic drugs designed for these reasons are key to targeting TAMs in the treatment of lung cancer. A large number of reports have suggested that natural compounds have a strong potential of affecting immunity by targeting the polarization and infiltration of TAMs to improve the immune microenvironment of lung cancer and exert a natural antitumor effect. This paper discusses the infiltration and polarization effects of natural compounds on lung cancer TAMs, provides a detailed classification and systematic review of natural compounds, and summarizes the bias of different kinds of natural compounds by affecting their antitumor mechanism of TAMs, with the aim of providing new perspectives and potential therapeutic drugs for targeted macrophages in the treatment of lung cancer. |
Keyword | Lung Cancer Macrophage Infiltration Macrophage Polarization Natural Compounds Tumor Associated Macrophages |
DOI | 10.1016/j.biopha.2022.113096 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Research & Experimental Medicine ; Pharmacology & Pharmacy |
WOS Subject | Medicine, Research & Experimental ; Pharmacology & Pharmacy |
WOS ID | WOS:000803896200001 |
Publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE |
Scopus ID | 2-s2.0-85129947122 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Corresponding Author | Sun, Changgang |
Affiliation | 1.College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China 2.College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China 3.College of Acupuncture and Massage, Shandong University of Traditional Chinese Medicine, Jinan, China 4.School of Traditional Chinese Medicine, Macau University of Science and Technology, Macau, Macao 5.State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, Macao 6.Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, China 7.College of Chinese Medicine, Weifang Medical University, Weifang, China 8.Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China |
Recommended Citation GB/T 7714 | Zhou, Xintong,Wang, Xiaomin,Sun, Qi,et al. Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer[J]. Biomedicine and Pharmacotherapy, 2022, 151. |
APA | Zhou, Xintong., Wang, Xiaomin., Sun, Qi., Zhang, Wenfeng., Liu, Cun., Ma, Wenzhe., & Sun, Changgang (2022). Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer. Biomedicine and Pharmacotherapy, 151. |
MLA | Zhou, Xintong,et al."Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer".Biomedicine and Pharmacotherapy 151(2022). |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment